Key result
Chronobiologic methods using 24-hour ambulatory blood pressure monitoring allow for individualized assessment of antihypertensive treatment efficacy compared to usual time-invariant limits.
Why the study?
Do chronobiologic methods using ambulatory monitoring improve the assessment of antihypertensive treatment efficacy compared to time-invariant blood pressure limits?
Do chronobiologic methods using ambulatory monitoring improve the assessment of antihypertensive treatment efficacy compared to time-invariant blood pressure limits?
Chronobiologic assessment using ambulatory blood pressure monitoring offers a more individualized and precise evaluation of antihypertensive efficacy than traditional static thresholds.
Answers are grounded in this paper and cite their sources.
May support individualized chronobiologic ABPM assessment; leaves open prospective validation versus time-invariant limits.
Chronobiologic methods are illustrated for the individualized assessment of the patient's response to antihypertensive medication. In addition to the 24-h mean from blood pressure profiles obtained by ambulatory monitoring, specific endpoints serve as gauges of treatment efficacy. These endpoints include the circadian amplitude, a measure of predictable extent of change within 24 h, and hyperbaric (or hypertensive) indices of excess or load. The latter indices assess the duration and amount of blood pressure excess by comparison to critical thresholds. In view of the large circadian variation characterizing blood pressure, the usual time-invariant limits of 140/90 mm Hg (systolic/diastolic) are replaced by time-specific 90% prediction limits derived from data of clinically healthy peers.< <ETX xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">></ETX>
No takes yet. Share an insight, caveat, or question.
Halberg et al. (2003) conducted a review in Hypertension. Chronobiologic methods vs. Time-invariant limits was evaluated on Patient's response to antihypertensive medication. Chronobiologic methods using 24-hour ambulatory blood pressure monitoring allow for individualized assessment of antihypertensive treatment efficacy compared to usual time-invariant limits.
Synapse has enriched 10 related papers. Consider them for comparative context: